People | December 13, 2022
Peter Bains appointed Additional Director of Biocon
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Revenue from operations up 26% to Rs. 768 crores
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
Company raises the annual revenue guidance from mid-teens to high teens
Syngene's collaboration with Zoetis started in 2011
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
Subscribe To Our Newsletter & Stay Updated
